Nothing Special   »   [go: up one dir, main page]

FR2990856B1 - USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS - Google Patents

USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS

Info

Publication number
FR2990856B1
FR2990856B1 FR1254697A FR1254697A FR2990856B1 FR 2990856 B1 FR2990856 B1 FR 2990856B1 FR 1254697 A FR1254697 A FR 1254697A FR 1254697 A FR1254697 A FR 1254697A FR 2990856 B1 FR2990856 B1 FR 2990856B1
Authority
FR
France
Prior art keywords
adipocytic
differentiation
act
active ingredient
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1254697A
Other languages
French (fr)
Other versions
FR2990856A1 (en
Inventor
Jean Paufique
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle Limousine dApplication Biologique SA SILAB
Original Assignee
Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Industrielle Limousine dApplication Biologique SA SILAB filed Critical Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority to FR1254697A priority Critical patent/FR2990856B1/en
Publication of FR2990856A1 publication Critical patent/FR2990856A1/en
Application granted granted Critical
Publication of FR2990856B1 publication Critical patent/FR2990856B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
FR1254697A 2012-05-23 2012-05-23 USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS Active FR2990856B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1254697A FR2990856B1 (en) 2012-05-23 2012-05-23 USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1254697A FR2990856B1 (en) 2012-05-23 2012-05-23 USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS

Publications (2)

Publication Number Publication Date
FR2990856A1 FR2990856A1 (en) 2013-11-29
FR2990856B1 true FR2990856B1 (en) 2014-07-04

Family

ID=46785585

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1254697A Active FR2990856B1 (en) 2012-05-23 2012-05-23 USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS

Country Status (1)

Country Link
FR (1) FR2990856B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868311B1 (en) * 2004-04-02 2006-08-11 Silab Sa METHOD FOR OBTAINING AN ACTIVE INGREDIENT AGAINST ADIPOCYTE DIFFERENTIATION AND LIPOLYTIC ACTIVITY
EP2262469A4 (en) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc Skin care compositions and methods of use thereof

Also Published As

Publication number Publication date
FR2990856A1 (en) 2013-11-29

Similar Documents

Publication Publication Date Title
UY34811A (en) COMPOUNDS AND COMPOSITIONS TO INHIBIT THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
HUE058161T2 (en) Anode active substance precursor for lithium secondary battery, anode active substance produced using it, and the lithium secondary battery containing it
EP2871180A4 (en) 2-AMINONICOTINIC ACID ESTER DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT
EP2892550A4 (en) STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
EP2859602A4 (en) DYNAMIC PRESSURE REGULATION IN BATTERY ASSEMBLY
EP2903617A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
DK2646044T3 (en) Methods to increase the intracellular activity of Hsp70
EP2631980A4 (en) NONAQUEOUS ELECTROLYTE SOLUTION
EA201400990A1 (en) INHIBITORS DIACYLGLYCERINACYLTRANSFERASE 2
EP2688404A4 (en) REGULATORS OF THE GROWTH OF PLANTS OF THE AUXINE TYPE
EP2615195A4 (en) NEGATIVE ELECTRODE STRUCTURE FOR ELECTRODE AND ELECTROLYTIC TANK USING THE SAME
FR2977151B1 (en) COSMETIC USE AS ANTI-TRANSPLANTING ACTIVE AN ALKALINE SILICATE
MA35439B1 (en) Inhibitors of the activating enzyme nedd8
EP2742361A4 (en) ANGIOPOIETIN-LIKE 4 AND ITS USE FOR MODULATING THE POROSITY OF CELLS
EP3882355C0 (en) DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATION DISORDERS WITH TELOMERASE INHIBITORS
EP2787071A4 (en) EPIC-CONTAINING CONCENTRATION AGENT CONTAINING PSICOSIS AS AN ACTIVE INGREDIENT
CL2014002095A1 (en) Electrode for the electrochemical decrease of chemical oxygen demand of industrial waste; electrochemical system; and procedure to reduce chemical oxygen demand.
EP2630956A4 (en) EXTENDED RELEASE PELLETS CONTAINING TACROLIMUS AS ACTIVE INGREDIENT
LT2782602T (en) NUCLEOTIDE DIMS0-150 FOR THE TREATMENT OF LOWER ACTIVE OPERATIVE COLOLIS
EP2552426A4 (en) DEVICE FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES IN VAGINA
FR2986430B1 (en) USE OF ACTIVE PRINCIPLE FROM EUCHEUMA COTTONII RICH IN LINEAR GALACTANES TO FIGHT CUTANEOUS CELL SENESCENCE
FR2993141B1 (en) USE OF 4-PHENYLBUTYRIC ACID TO ENHANCE PLANT TOLERANCE TO BIOAGRESSORS
FR2989275B1 (en) ACTIVE SKIN APPLICATION PRINCIPLE OBTAINED FROM METSCHNIKOWIA AGAVES AND USES FOR IMPROVING THE CONDITION OF THE SKIN
FR2945209B1 (en) COSMETIC USE OF AN ACTIVE INGREDIENT FROM LENS CULINARIS OR LENS ESCULENTA TO FIGHT THE EXPANSION OF PORES.
FR2990856B1 (en) USE OF AN ACTIVE INGREDIENT FROM CELOSIA CRISTATA TO ACT ON THE DIFFERENTIATION OF ADIPOCYTIC STEM CELLS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13